This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (38)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David H. Abramson, MD; Robert M. Ellsworth, MD; Patricia Tretter, MD; Kimberly Adams, MD; F. David Kitchin, MD

Arch Ophthalmol. 1981;99(10):1763-1766.

Abstract
• A retrospective review of 1,424 cases of retinoblastoma disclosed 34 patients with advanced bilateral retinoblastoma whose sole initial treatment was simultaneous bilateral radiation. All patients had a combination of bilateral group IV or V retinoblastoma. Mean age at diagnosis was 13.1 months. Five-year survival of patients was 88% (28/32). In two (7%) of 28 surviving patients, a second nonocular tumor developed: one inside and one outside the field of radiation. Of the 64 eyes treated, 44 ultimately were enucleated. Of ten eyes requiring a second course of radiation, nine were enucleated. In only one eye was enucleation due to radiation complications. Eleven patients required additional treatment with light coagulation, cryopexy, or cobalt plaques.

Author Affiliations
From the New York Hospital-Cornell Medical Center (Drs Abramson, Ellsworth, Adams, and Kitchin) and Columbia-Presbyterian Medical Center (Dr Tretter), New York.

Footnotes
Accepted for publication Jan 12, 1981.

Reprint requests to 70 E 66th St, New York, NY 10021 (Dr Abramson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Iontophoretic delivery of Carboplatin in a murine model of retinoblastoma.
Hayden et al.
IOVS 2006;47:3717-3721.
ABSTRACT | FULL TEXT  

Outcome Following Initial External Beam Radiotherapy in Patients With Reese-Ellsworth Group Vb Retinoblastoma
Abramson et al.
Arch Ophthalmol 2004;122:1316-1323.
ABSTRACT | FULL TEXT  

External Beam Radiation "Salvage" Therapy in Transgenic Murine Retinoblastoma
Sobrin et al.
Arch Ophthalmol 2004;122:251-257.
ABSTRACT | FULL TEXT  

Eye-Preservation Treatment of Retinoblastoma with Vitreous Seeding
Kaneko and Suzuki
Jpn J Clin Oncol 2003;33:601-607.
ABSTRACT | FULL TEXT  

External Beam Radiotherapy in Retinoblastoma: Tumor Control and Comparison of 2 Techniques
Scott et al.
Arch Ophthalmol 1999;117:766-770.
ABSTRACT | FULL TEXT  

The Outcome of Chemoreduction Treatment in Patients With Reese-Ellsworth Group V Retinoblastoma
Gunduz et al.
Arch Ophthalmol 1998;116:1613-1617.
ABSTRACT | FULL TEXT  

Intraocular Concentrations of Chemotherapeutic Agents After Systemic or Local Administration
Mendelsohn et al.
Arch Ophthalmol 1998;116:1209-1212.
ABSTRACT | FULL TEXT  

Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without Radiotherapy
Gallie et al.
Arch Ophthalmol 1996;114:1321-1328.
ABSTRACT  

Results of Combined Chemotherapy and Radiotherapy for Advanced Intraocular Retinoblastoma
Kingston et al.
Arch Ophthalmol 1996;114:1339-1343.
ABSTRACT  

Penetration of Chemotherapy Into Vitreous Is Increased by Cryotherapy and Cyclosporine in Rabbits
Wilson et al.
Arch Ophthalmol 1996;114:1390-1395.
ABSTRACT  

The Management of Unilateral Retinoblastoma Without Primary Enucleation
Abramson et al.
Arch Ophthalmol 1982;100:1249-1252.
ABSTRACT  

Retreatment of Retinoblastoma With External Beam Irradiation
Abramson et al.
Arch Ophthalmol 1982;100:1257-1260.
ABSTRACT  

Treatment of Bilateral Groups I Through III Retinoblastoma With Bilateral Radiation
Abramson et al.
Arch Ophthalmol 1981;99:1761-1762.
ABSTRACT